is the standard expression of the relationship between carbon dioxide excretion and alveolar ventilation at a given alveolar carbon dioxide concentration, with the term (Pa -PH20 ) inserted to convert fractional carbon dioxide concentration to partial pressure. The second term,
9"CO2(PB-PH20)

VF
isan expression for the Pco2 of the mixed exhaled gas within the system which is available for rebreathing. The last term, *~r E __ ~r F VE expresses the degree of rebreathing which occurs at given values of "Q'E and ~'e. (For a formal derivation of this equation, see de Silva's paper, s) Equation (l) was modified as follows: Assuming
where VD/VT = physiologic dead space/tidal volume ratio, and
where Paco 2 = arterial partial pressure of carbon dioxide, torr; then, substituting (2) and (3) into (1),
Equation (4) was written into a programme for use with a Hewlett-Packard HP-97 calculator, whereby Pacoz could be calculated for given values of Vco2, Vo/VT, VE and VF. The term (1% -PH20) was assigned the value 713.
2. Mechanical Model. Figure 1 illustrates the mechanical model. An artificial "lung" was constructed of two anaesthesia breathing bags joined with a Y-connector. Carbon dioxide gas in metered quantities (a controllable "~'co~") was flowed into the tail of one bag (the "alveolus"). A controllable "physiological dead space" was provided by the second bag, the volume of which could be changed by altering the position of a clamp. Values of VD/VT were only roughly estimated.
The breathing system included an Air-Shields anaesthesia ventilator by which known minute volume was delivered. ~'E was measured with a Wright ventilometer. 'r was provided as oxygen through the flowmeter of an Ohio "2000" series anaesthesia machine. To determine "Paco.2 ", carbon dioxide concentration was measured with an infrared analyzer at the neck of the "alveolus" breathing bag. The analyzer was calibrated with known concentrations of carbon dioxide. Fl'aclional concentrations were converted to partial pressure by multiplying with 713. The model system was completed by insertion of a commercially obtained Bain Breathing Circuit, as illustrated in Figure i , or an anaesthetic circle absorber system of the Eger-Ethans type A (fresh gas inflow between inspiratory valve and patient), 6 with soda lime excluded.
"Paco2+' was measured at various settings of VD/VT, ~/CO2, VE and ~/F. At least 15 minutes were allowed at each setting before Pacoz was measured. It was assumed that the model weighed 70 kg, and values for Vco=, "V'E and ~/f Figure 2 demonstrates the relationship between Pacoz and ~'F found with the mechanical and mathematical models. The circles represent actual measurements of Paco., at various fresh gas flows (~'F) with the mechanical model. ~co2 was held constant at 2.25 ml/kg, VD/VT at 0.5, and X/E at 140 ml/kg. These values of Vco2 and VD/VT are typical for anaesthetized, artifically ventilated humansd '8 Data from both the Bain Breathing Circuit (open circles) and circle system (closed circles) are included.
RESU LTS
The solid curve in Figure 2 represents calculated Paco~ values produced by the mathematical model at various assigned values of 9 r , when Vco: = 2.25 ml/kg, VD/VT = 0.5, and ~E = 140 ml/kg. Figure 2 demonstrates that the mathematical model, and the mechanical model with both breathing systems, performed identically.
To test whether this identity of performance holds when values of Vco2, VD/VT, and ~'E are varied, VF was held constant at 70 ml/kg while each of those parameters was varied individually. 
It has often been suggested that Paco,, is independent of changes in ventilation (provided ventilation exceeds normal) with rebreathing systems. 1.2.3.9.12 Figure 3C demonstrates that this is not precisely correct. It is only when VE exceeds 160 ml/kg, which is nearly double the normal figure, that Pacoz becomes relatively insensitive to changes in VE. Thus, if precision control of Paco~ is desired, as in neuroanaesthesia, then V'E must be measured and controlled in rebreathing systems,just as in nonrebreathing systems. The fact that Bain and Spoerel did not precisely specify a value for ~'E in their clinical studies may account for the slight discrepancy seen between their data and those from the models in this study. Bain and Spoerel recommended tidal volumes of at least 10 ml/kg, with respiratory rates of 12 to 16 per minute. Thus, ~'E could have been from 120 to over 160 ml/kg in their patients, whereas in this study '(/E was fixed at 140 ml/kg for the data presented in Figures 2 and 4 . It is also probable that the scatter in the data reported by Bain and Spoerel would have been less had a fixed value of ~'E been used.
It is not surprising that 'r and VD/VT would affect the Paco2 produced by a rebreathing system, as they play a role in all ventilatory systems. It is well known that these variables are not exactly predictable. ~3 Therefore a certain imprecision in estimating Paco2 with rebreathing systems is an inevitable fact of clinical life. But with the other factors ('V'F and VE) controlled, the imprecision should be no greater than with other methods of artificial ventilation.
The variable VO/VT provides a key to the understanding of how rebreathing systems work. Bain and Spoerel, following the prediction that fresh gas flow controls Paco2, proposed that the equation VC02 (PB --PH20) (5) Pac~ = •F should be valid for a rebreathing system. 3 Yet when they compared theoretical calculations from this equation with their own clinical results, a large discrepancy was seen, for which the authors had "no satisfactory explanation." It can now be shown that physiological dead space, or wasted ventilation,* can provide the explanation. Figure 5 demonstrates the effect of wasted ventilation. Using the mathematical model (equation 4), the relationship between ~'F and Paco2 was calculated at two values of VD/VT when VCO2 = 2.25 ml/kg and '(/E = 140 ml/kg. The solid curve (VD/VT = 0.5) is a duplicate of that in Figure 4 which was used for comparison with the clinical data of Bain and Spoerel. ~ The dashed curve (VD/VT = 0) describes what would occur if there were no wasted ventilation. Interestingly, the dashed curve is also produced by equation (5) when the same value for ~/coz (2.25 ml/kg) is used. Furthermore, equation (4) can be reduced algebraically to equation (5) when VD/VT = 0. Therefore, the discrepancy between what Bain and SpoereI predicted with equation (5) and what actually occurs with a rebreathing system may be accounted for by the presence of wasted ventilation.
It appears that wasted ventilation makes V'F inefficient in its removal of carbon dioxide. For example, Figure 5 demonstrates that when VD/VT = 0, a VF of only 65 ml/kg is required to produce a Pacoz of 25 torr. Yet when VD/VT = 0.5 almost twice as much 'QF (120 ml/kg) is required; obviously only half the fresh gas reaches actively exchanging alveoli when VD/VT = 0.5. The other half reaches underperfused or unperfused alveoli and is "wasted". What is less obvious, but just as important to the understanding of rebreathing systems, is that the proportion of~'F wasted with a given VD/VT is not always the same. Figure 5 shows that the two curves tend to converge as VF decreases, suggesting that the effect of wasted ventilation is progressively diminished as the value for "V'F is reduced. Thus, for example when *The term "wasted ventilation," for the purposes of this discussion, may be considered identical to physiological dead space, as described by West. '4 Briefly, it is "made up of contributions from alveoli which have ventilation-perfusion ratios exceeding that of ideal alveoli, and the volume of gas contained in the anatomic dead space." VD/VT = 0, a VF of 30 ml/kg produces a Pacozof 50 tore Yet when VD/VT = 0.5, a VF of only 42 ml/kg produces the same Paco2, although one would expect the required ~/F to be 60 ml/kg, if half the VF were wasted. Obviously, some factor is at work at low values of VF which directs a portion of the "'wasted" VF back into effectively exchanging alveoli.
This factor is rebreathing. Some of the fresh gas (~'F) which is initially breathed into unperfused alveoli may be re-breathed into effectively exchanging alveoli. The extent to which this phenomenon occurs will be determined by the extent to which rebreathing occurs. The fraction (from equation 4) VF. -~F #E defines the extent of rebreathing. Thus when VE is held constant a decrease in X~F will bring about a proportionate increase in rebreathing. This explains why the two curves in Figure 5 tend to converge at low values of ~/v. Therefore, the dynamics of carbon dioxide control in a rebreathing system may be characterized as an interaction of wasted ventilation and rebreathing on the effect of fresh gas flow. Wasted ventilation tends to diminish and rebreathing tends to enhance the efficiency of fresh gas flow in the removal of carbon dioxide from a rebreathing system. It is expected that the equation will be useful in the clinical application of rebreathing anaesthetic systems, allowing the selection of minute volumesand fresh gas flows which will yield predictable Paco.2 values. Cette 6quation apparalt d'utilit6 clinique cat" rile permet la s61ection des volumes de ventilation-minute et des d6bits de gaz fi'ais n6cessaires pout" maintenir la Pco2 ~ des niveaux pr6visibles.
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